These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 22632862)

  • 21. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.
    Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; Krook JE; Wilwerding MB; Rowland KM; Camoriano JK; Novotny PJ; Christensen BJ
    J Clin Oncol; 1999 Oct; 17(10):3299-306. PubMed ID: 10506633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer cachexia: molecular mechanism and pharmacological management.
    Li Y; Jin H; Chen Y; Huang T; Mi Y; Zou Z
    Biochem J; 2021 May; 478(9):1663-1688. PubMed ID: 33970218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IUPHAR ECR review: Cancer-related anorexia-cachexia in cancer patients: Pathophysiology and treatment.
    Chowdhury IH; Rahman S; Afroze YJ; Shovah ST
    Pharmacol Res; 2024 May; 203():107129. PubMed ID: 38461961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cachexia and anorexia: cancer's covert killer.
    Davis MP; Dickerson D
    Support Care Cancer; 2000 May; 8(3):180-7. PubMed ID: 10789957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonsteroidal Anti-Inflammatory Drugs in Patients with Anorexia-Cachexia Syndrome Associated with Malignancy and Its Treatments.
    Garcia JM; Shamliyan TA
    Am J Med; 2017 Sep; 130(9):1033-1036. PubMed ID: 29016346
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis.
    Leśniak W; Bała M; Jaeschke R; Krzakowski M
    Pol Arch Med Wewn; 2008 Nov; 118(11):636-44. PubMed ID: 19140567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modern management of the cancer anorexia-cachexia syndrome.
    Nelson KA
    Curr Oncol Rep; 2000 Jul; 2(4):362-8. PubMed ID: 11122866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are cannabinoids an alternative for cachexia-anorexia syndrome in patients with advanced cancer?
    Cabeza C; Corsi O; Pérez-Cruz P
    Medwave; 2017 Dec; 17(9):e7130. PubMed ID: 29286357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist.
    Esposito A; Criscitiello C; Gelao L; Pravettoni G; Locatelli M; Minchella I; Di Leo M; Liuzzi R; Milani A; Massaro M; Curigliano G
    Cancer Treat Rev; 2015 Nov; 41(9):793-7. PubMed ID: 26386985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current and future care of patients with the cancer anorexia-cachexia syndrome.
    Del Fabbro E
    Am Soc Clin Oncol Educ Book; 2015; ():e229-37. PubMed ID: 25993178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic management of anorexia/cachexia.
    Ottery FD; Walsh D; Strawford A
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):35-44. PubMed ID: 9625382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.
    DeBoer MD
    Curr Pharm Des; 2012; 18(31):4779-99. PubMed ID: 22632859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Appetite stimulants for patients with cancer: current evidence for clinical practice.
    Turcott JG; Zatarain-Barrón ZL; Cárdenas Fernández D; Castañares Bolaños DT; Arrieta O
    Nutr Rev; 2022 Mar; 80(4):857-873. PubMed ID: 34389868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review).
    Strang P
    Anticancer Res; 1997; 17(1B):657-62. PubMed ID: 9066597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress.
    Mantovani G; Macciò A; Madeddu C; Gramignano G; Lusso MR; Serpe R; Massa E; Astara G; Deiana L
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1030-4. PubMed ID: 16702388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cannabinoids in the treatment of the cachexia-anorexia syndrome in palliative care patients].
    Nauck F; Klaschik E
    Schmerz; 2004 Jun; 18(3):197-202. PubMed ID: 15221423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia.
    Loprinzi CL; Ellison NM; Schaid DJ; Krook JE; Athmann LM; Dose AM; Mailliard JA; Johnson PS; Ebbert LP; Geeraerts LH
    J Natl Cancer Inst; 1990 Jul; 82(13):1127-32. PubMed ID: 2193166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial.
    Inoue T; Takagi H; Owada Y; Watanabe Y; Yamaura T; Fukuhara M; Muto S; Okabe N; Matsumura Y; Hasegawa T; Osugi J; Hoshino M; Higuchi M; Shio Y; Yokouchi H; Kanazawa K; Ohbuchi K; Fukushima T; Munakata M; Suzuki H
    Trials; 2017 Oct; 18(1):485. PubMed ID: 29047408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.
    Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):45-52. PubMed ID: 9625383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical management of anorexia and cachexia in patients with advanced cancer.
    Bruera E
    Oncology; 1992; 49 Suppl 2():35-42. PubMed ID: 1461626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.